Introduction: Bevacizumab has shown promising activity in neuroendocrine tumors (NET) in combination with a multitude of other substances.
Aim(s): To analyze the efficacy and toxicity of bevacizumab-containing protocols in NET.
Materials and methods: We performed a retrospective analysis of all patients treated with bevacizumab-containing protocols for metastatic NET who presented at our center between August 2008 and December 2014.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr. med. Leonidas Apostolidis
To read results and conclusion, please login ...
Further abstracts you may be interested in